Phathom Pharmaceuticals, Inc. Schedule 13G filing reports that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander together beneficially hold 4,178,411 shares of common stock, representing 5.3% of the class as of 03/06/2026. The filing discloses shared voting and shared dispositive power over those 4,178,411 shares.
Positive
None.
Negative
None.
Insights
Disclosure shows a passive, reportable stake controlled by Millennium-related entities.
The filing identifies Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander as a reporting group holding 4,178,411 shares (5.3%) as of 03/06/2026. The filing attributes shared voting and shared dispositive power; signatures and a Joint Filing Agreement are included.
Future filings or amendments may disclose changes in voting arrangements or group composition; current disclosures show a standard joint filing under the Schedule 13G framework.
Stake size is reportable but below common controlling thresholds.
The group reports beneficial ownership of 4,178,411 shares, equating to 5.3% of the outstanding class as of 03/06/2026. The disclosed position is recorded with shared voting and dispositive powers rather than sole control.
Cash‑flow treatment and intent (passive vs. active) are not stated; subsequent Schedule 13D or Form 4 filings would indicate activism or transactions.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Phathom Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
03/06/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Millennium Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,178,411.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,178,411.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,178,411.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Millennium Group Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,178,411.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,178,411.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,178,411.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Israel A. Englander
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,178,411.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,178,411.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,178,411.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.3 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Phathom Pharmaceuticals, Inc.
(b)
Address of issuer's principal executive offices:
100 Campus Drive, Suite 102, Florham Park, New Jersey 07932
Item 2.
(a)
Name of person filing:
Millennium Management LLC
Millennium Group Management LLC
Israel A. Englander
(b)
Address or principal business office or, if none, residence:
Millennium Management LLC
399 Park Avenue
New York, New York 10022
Millennium Group Management LLC
399 Park Avenue
New York, New York 10022
Israel A. Englander
c/o Millennium Management LLC
399 Park Avenue
New York, New York 10022
(c)
Citizenship:
Millennium Management LLC - Delaware
Millennium Group Management LLC - Delaware
Israel A. Englander - United States
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
71722W107
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See response to Item 9 on each cover page.
(b)
Percent of class:
See response to Item 11 on each cover page.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See response to Item 5 on each cover page.
(ii) Shared power to vote or to direct the vote:
See response to Item 6 on each cover page.
(iii) Sole power to dispose or to direct the disposition of:
See response to Item 7 on each cover page.
(iv) Shared power to dispose or to direct the disposition of:
See response to Item 8 on each cover page.
The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit I
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Millennium Management LLC
Signature:
/s/ Gil Raviv
Name/Title:
Gil Raviv, Global General Counsel
Date:
03/11/2026
Millennium Group Management LLC
Signature:
/s/ Gil Raviv
Name/Title:
Gil Raviv, Global General Counsel
Date:
03/11/2026
Israel A. Englander
Signature:
/s/ Israel A. Englander
Name/Title:
Israel A. Englander
Date:
03/11/2026
Exhibit Information
Exhibit I: Joint Filing Agreement, dated as of March 11, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.
What stake does Millennium report in Phathom (PHAT)?
The filing states 4,178,411 shares, equal to 5.3% of common stock as of 03/06/2026. The reported stake is held with shared voting and dispositive power among the Millennium entities and Israel A. Englander.
Who are the reporting parties on the Schedule 13G for PHAT?
The Schedule 13G lists Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander as filers, with addresses at 399 Park Avenue, New York, NY, and a Joint Filing Agreement dated 03/11/2026.
Does the filing show sole control of the shares?
No. The filing reports 0 sole voting power and 0 sole dispositive power; it discloses shared voting and shared dispositive power over the 4,178,411 shares reported.
Is this Schedule 13G equivalent to an activist filing?
No. A Schedule 13G generally indicates a passive reporting status. The filing here reports beneficial ownership and shared powers but does not state activist intent; any change in intent would typically prompt a Schedule 13D.
When were the ownership figures reported in the PHAT filing?
The ownership amount is reported as of 03/06/2026, and the signatures and Joint Filing Agreement in the filing are dated 03/11/2026.
